These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29942136)

  • 1. Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis.
    Ma HF; Lv GX; Cai ZF; Zhang DH
    Onco Targets Ther; 2018; 11():3441-3447. PubMed ID: 29942136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Optimal Treatment for Resectable Esophageal Cancer: A Network Meta-Analysis of 6168 Patients.
    Yuan M; Bao Y; Ma Z; Men Y; Wang Y; Hui Z
    Front Oncol; 2021; 11():628706. PubMed ID: 33777777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
    Pasquali S; Yim G; Vohra RS; Mocellin S; Nyanhongo D; Marriott P; Geh JI; Griffiths EA
    Ann Surg; 2017 Mar; 265(3):481-491. PubMed ID: 27429017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traditional and cumulative meta-analysis: Chemoradiotherapy followed by surgery versus surgery alone for resectable esophageal carcinoma.
    Feng H; Zhao Y; Jing T; Ma J; Zhao Y; Zhang J; Wang C; Li B
    Mol Clin Oncol; 2018 Feb; 8(2):342-351. PubMed ID: 29435301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H
    Am J Surg; 2003 Jun; 185(6):538-43. PubMed ID: 12781882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant treatments for resectable rectal cancer: A network meta-analysis.
    Zhong W; Xue X; Dai L; Li R; Nie K; Zhou S
    Exp Ther Med; 2020 Apr; 19(4):2604-2614. PubMed ID: 32256740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H; Blewett CJ
    Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis.
    Xu CP; Xue XJ; Liang N; Xu DG; Liu FJ; Yu XS; Zhang JD
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):549-59. PubMed ID: 24370686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.
    Jin HL; Zhu H; Ling TS; Zhang HJ; Shi RH
    World J Gastroenterol; 2009 Dec; 15(47):5983-91. PubMed ID: 20014464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
    Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
    Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Malthaner R; Fenlon D
    Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis.
    Fan M; Lin Y; Pan J; Yan W; Dai L; Shen L; Chen K
    Thorac Cancer; 2016 Mar; 7(2):173-81. PubMed ID: 27042219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.
    Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD
    World J Gastroenterol; 2009 Oct; 15(39):4962-8. PubMed ID: 19842230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of neoadjuvant regimens for resectable gastroesophageal junction cancer: a systematic review of randomized clinical trials across three decades.
    Nishikawa G; Banik P; Thawani R; Kardosh A; Wood SG; Nabavizadeh N; Chen EY
    J Gastrointest Oncol; 2022 Jun; 13(3):1454-1466. PubMed ID: 35837173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma.
    Luo H; Cui YY; Zhang JG; Sun YN; Zheng XL; Yang CL; Ye K; Ge H
    Clin Transl Oncol; 2018 Jul; 20(7):889-898. PubMed ID: 29143229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of Neoadjuvant and Adjuvant Therapy Compared With Surgery Alone for Resectable Esophageal Squamous Cell Carcinoma: A Systemic Review and Network Meta-Analysis.
    Ma Z; Yuan M; Bao Y; Wang Y; Men Y; Hui Z
    Front Oncol; 2021; 11():728185. PubMed ID: 34745950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant chemoradiotherapy in treatment of resectable esophageal carcinoma: a meta-analysis.
    Zheng B; Zheng W; Zhu Y; Lin XY; Xu BH; Chen C
    Chin Med J (Engl); 2013 Mar; 126(6):1178-82. PubMed ID: 23506601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma.
    Deng J; Wang C; Xiang M; Liu F; Liu Y; Zhao K
    Diagn Pathol; 2014 Jul; 9():151. PubMed ID: 25030066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.